|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||59.90 - 61.05|
|52-week range||59.10 - 129.79|
|Beta (5Y monthly)||0.34|
|PE ratio (TTM)||45.37|
|Forward dividend & yield||1.50 (1.82%)|
|Ex-dividend date||29 Mar 2021|
|1y target est||101.91|
Image source: The Motley Fool. Biogen inc (NASDAQ: BIIB)Q3 2021 Earnings CallOct 20, 2021, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning.
Citius Pharmaceuticals (CTXR) acquires Dr. Reddy's exclusive license rights for E7777 to treat a rare form of NHL and other cancer indications.
BIIB earnings call for the period ending June 30, 2021.